Advertising disclosure — We may earn a commission if you start care through some of these links, at no extra cost to you. How we're funded. Order reflects our editorial rubric and our commercial relationships; scores are ours alone.
Head-to-head for women
Eden vs MyDrHank
Eden and MyDrHank both offer GLP-1 telehealth to women, but they make different trade-offs on PCOS and hormonal suitability, clinical oversight, price and access. Here they are side-by-side on the Luna Fit Score — our women's-health rubric.
Eden
Higher scoreRanked #3 for women · Grade B+
Luna Fit
Best for: Women who value knowing exactly who is prescribing and where the medication comes from, and will pay above the cheapest tiers for that transparency.
FDA warning letterJune 2026Read it ↗Visit EdenMyDrHank
Ranked #50 for women · Grade C
Luna Fit
Best for: Readers treating insulin resistance who want tirzepatide at a price that does not climb with the dose, and who will open the plan selector and pay the month-to-month rate rather than the advertised one.
Visit MyDrHankThe verdict for women
Eden edges out MyDrHank on the Luna Fit Score, 88 to 73 (B+ vs C). Women who value knowing exactly who is prescribing and where the medication comes from, and will pay above the cheapest tiers for that transparency. The reasoning behind that number is in our Eden write-up for women.
MyDrHank is still a genuine option — a flat, all-dose price on both molecules — including the tirzepatide most insulin-resistance readers are actually here for — from a general telehealth shop that publishes its ladder openly but shows you only the twelve-month rung of it. Weigh the six women's-health factors below against your own priorities; our MyDrHank write-up for women goes through each of them, and if neither of these two is the one, what women pick instead of MyDrHank widens the field.
Side-by-side on the six factors
Both providers scored on the same women's-health rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | Eden | MyDrHank |
|---|---|---|
| Luna Fit Score | 88/100 · B+ | 73/100 · C |
| Overall rank | #3 | #50 |
| Semaglutide | $239/mo | $259/mo month-to-month (from $178/mo on a 12-month prepay, $2,140 up front) — the site displays only the prepay rate |
| Tirzepatide | $349/mo | $349/mo month-to-month (from $240/mo on a 12-month prepay, $2,883 up front) — the site displays only the prepay rate |
| Coverage | All 50 states | No state list published; its affiliate terms exclude Kansas, Louisiana, Mississippi, New Mexico, North Dakota and West Virginia |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Yes |
Luna Fit
Eden
Ranked #3 · Grade B+
What we like
- Clear clinician and supply-chain disclosure — among the most transparent in the ranking about who and what is behind the prescription
- Nationwide availability with both molecules
- High verification confidence: the facts it publishes hold up when checked
The caveats
- Premium pricing versus the cheapest tiers
- Compounded only — no brand-name access
- Not a hormone-specialty clinic; PCOS framing is general
Luna Fit
MyDrHank
Ranked #50 · Grade C
What we like
- Tirzepatide is a first-class option here, not an upsell — the dual GIP/GLP-1 agonist is the one most readers arriving on insulin-resistance questions ask about by name
- The price does not move with the dose: its GLP-1 FAQ states "the price stays the same at every dose — no surprise price increases", so a titration to a higher dose does not re-price the plan
- Prices are published before any intake quiz — the full four-rung ladder for every product, with the up-front total beside each per-month figure, rather than a number you have to qualify for
The caveats
- Every price the site displays is the TWELVE-MONTH PREPAY rate — the renderer takes the cheapest rung of the ladder — so the month-to-month figures ($349 tirzepatide, $259 semaglutide) are shown on no page at all
- Its own footnote advertises a tirzepatide price that exists at no tier: "Plans start at $171/mo for compounded semaglutide and $200/mo for compounded tirzepatide" — $200 appears exactly once in the entire site bundle and no tirzepatide rung costs it; the $171 in the same sentence is the ORAL product's yearly rate, while injectable semaglutide's is $178
- The GLP-1 FAQ calls a prepaid annual rate a plan with "no contract", which is true of the paperwork and misleading about the money
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. Pricing, states and verification reflect each provider's public disclosures at last review; the Luna Fit Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Neither Eden nor MyDrHank is only worth comparing with the other. Eden is also written up against Ondra Health, an exact tie on the Luna Fit Score — see the Eden–Ondra Health head-to-head. MyDrHank is also written up against CoreAge Rx, 20 points apart — see MyDrHank against CoreAge Rx, factor by factor.
- Eden vs CoreAge Rx
- Eden vs Enhance MD
- Eden vs yourEra
- MyDrHank vs Sesame Care
- MyDrHank vs HealthRX
- MyDrHank vs MadeMed
Or browse the full comparison hub.